01.19.24 -- Emerging Trends & Technologies In Anti-Counterfeit Pharmaceutical Packaging

Reduce the number of chromatography steps you are taking in your monoclonal antibody (mAb) purification process by implementing a mixed-mode chromatography approach.

In this study, we present a second-generation purification procedure for adenoviral vectors based on monolith chromatography that secures safer products and enhances purity at higher yields.

In this assessment of the in vitro glycoengineering technology we determine if it is suitable for the development, manufacturing, and analysis of therapeutic proteins.

Are you wasting time with data you ultimately can’t use because they're not reproducible? Learn how to safeguard your data quality by ensuring your HPLC instrument remains consistently in peak condition.

Are you in the process of choosing an automated colony picking solution? Take an in-depth look at currently available microbial and mammalian clone screening devices.

Evaluate the consistency, linearity, and specificity of a plug-and-play, in-line, Raman-based PAT solution that typically provides measurements with a precision of <0.1 g/L for both glucose and lactate.

Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.

Explore the benefits of using mRNA for vaccines and therapeutics, and learn how to address technical, intellectual property, and cost considerations when considering commercial production.

Learn about the rising demand for cleanrooms in the biopharmaceutical industry, factors driving cleanroom design, building in flexibility, the role of critical path assessments, and more.

See how the different unit operations in a laboratory-scale monoclonal antibody (mAb) process can be connected and integrated into a semicontinuous process.

Organizations developing products requiring fermentation often create custom processes from scratch, leaving room for inefficiencies, lost value, and, in the case of significant error, costly time delays.